Articles from Cryofocus Medtech (Shanghai) Co., Ltd.

Cryofocus Announces 2026 Interim Results: Loss Narrows 37.9% to RMB 16.9 Million, Gross Margin Improves to 68.5%
Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products
Articles from Cryofocus Medtech (Shanghai) Co., Ltd. | MarketMinute